We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
476
Stevens Capital Management
Pennsylvania
$7.06M +$3.81M +36,784 +104%
SAM
477
Securian Asset Management
Minnesota
$6.99M -$595K -5,749 -7%
MYAM
478
Meiji Yasuda Asset Management
Japan
$6.96M -$112K -1,084 -1%
FMI
479
Factory Mutual Insurance
Massachusetts
$6.94M
WA
480
Waverly Advisors
Alabama
$6.9M +$513K +4,951 +8%
BAMCO Inc
481
BAMCO Inc
New York
$6.83M -$1.04M -10,000 -13%
MGM
482
Miura Global Management
New York
$6.83M +$5.18M +50,000 +250%
SGH
483
Sivik Global Healthcare
Connecticut
$6.83M -$1.04M -10,000 -13%
SEIA
484
Signature Estate & Investment Advisors
California
$6.83M +$431K +4,164 +6%
SAM
485
Silvercrest Asset Management
New York
$6.81M +$154K +1,486 +2%
MF
486
Magnetar Financial
Illinois
$6.78M +$6.6M +63,691 +1,102%
Walleye Trading
487
Walleye Trading
New York
$6.71M -$6.28M -60,675 -47%
AIM
488
Aigen Investment Management
New York
$6.7M +$29.9K +289 +0.4%
EAM
489
EdenTree Asset Management
United Kingdom
$6.63M
KOCAA
490
Knights of Columbus Asset Advisors
Connecticut
$6.61M -$120K -1,161 -2%
CB
491
Commerce Bank
Missouri
$6.6M +$303K +2,922 +5%
BWL
492
Bogart Wealth LLC
Virginia
$6.6M +$163K +1,571 +2%
NMERB
493
New Mexico Educational Retirement Board
New Mexico
$6.53M -$207K -2,000 -3%
TGIA
494
Torrey Growth & Income Advisors
California
$6.52M +$6.91M +66,743 New
Envestnet Portfolio Solutions
495
Envestnet Portfolio Solutions
Illinois
$6.51M +$75.6K +730 +1%
MGP
496
Metis Global Partners
California
$6.48M +$49.5K +478 +0.7%
GCM
497
Graham Capital Management
Connecticut
$6.47M -$11.8M -113,835 -63%
ET
498
Entropy Technologies
New York
$6.37M -$1.82M -17,530 -21%
ETC
499
Exchange Traded Concepts
Oklahoma
$6.31M +$2.36M +22,791 +54%
LFG
500
Larson Financial Group
Missouri
$6.31M +$135K +1,308 +2%

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.